Trials / Sponsors / Ellodi Pharmaceuticals, LP
Ellodi Pharmaceuticals, LP
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) Eosinophilic Esophagitis | Phase 3 | 2022-12-29 |
| Completed | Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the F Eosinophilic Esophagitis | Phase 3 | 2021-09-30 |
| Completed | Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) Eosinophilic Esophagitis | Phase 3 | 2020-01-30 |
| No Longer Available | Expanded Access Protocol for Patients With Eosinophilic Esophagitis Eosinophilic Esophagitis | — | — |